Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Net Income towards Common Stockholders of $233 million in Q3 2026, down 46.2% from $433 million a year earlier.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
On a TTM basis, Teva Pharmaceutical Industries' Net Income towards Common Stockholders came in at $506 million as of Sep 30, 2026, down 28.9% year-over-year; for FY2025, it came in at $1.41 billion.
- Across earlier years, Net Income towards Common Stockholders came in at -$1.64 billion in FY2024, -$559 million in FY2023, -$2.45 billion in FY2022 and $417 million in FY2021.
- Quarterly Net Income towards Common Stockholders has ranged from -$1.3 billion in Q4 2022 to $480 million in Q4 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$576 million (Q2 2026), $369 million (Q1 2026) and $480 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,231.10 Bn | 1,204.71 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 669.11 Bn | 588.97 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 513.20 Bn | 481.21 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 361.72 Bn | 324.66 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 313.59 Bn | 286.83 Bn | - | - |
| 6 | Astrazeneca | 290.36 Bn | 264.25 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 246.51 Bn | 198.16 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 206.71 Bn | 181.82 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 165.30 Bn | 112.66 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Teva Pharmaceutical Industries | 49.75 Bn | 34.72 Bn | 2.44 Bn | 233.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 233.00 Mn |
| Jun 30, 2026 | -576.00 Mn |
| Mar 31, 2026 | 369.00 Mn |
| Dec 31, 2025 | 480.00 Mn |
| Sep 30, 2025 | 433.00 Mn |
| Jun 30, 2025 | 282.00 Mn |
| Mar 31, 2025 | 214.00 Mn |
| Dec 31, 2024 | -217.00 Mn |
| Sep 30, 2024 | -437.00 Mn |
| Jun 30, 2024 | -846.00 Mn |
| Mar 31, 2024 | -139.00 Mn |
| Dec 31, 2023 | 463.00 Mn |
| Sep 30, 2023 | 69.00 Mn |
| Jun 30, 2023 | -872.00 Mn |
| Mar 31, 2023 | -220.00 Mn |
| Dec 31, 2022 | -1.30 Bn |
| Sep 30, 2022 | 61.00 Mn |
| Jun 30, 2022 | -251.00 Mn |
| Mar 31, 2022 | -955.00 Mn |
| Dec 31, 2021 | -159.00 Mn |
API Access
Teva Pharmaceutical Industries Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();